You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 38 No. 7, July 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Increased Serum Levels of Nerve Growth Factor in von Recklinghausen's Disease

Robert N. Fabricant, MD; George J. Todaro, MD

Arch Neurol. 1981;38(7):401-405.


Abstract

• Serum samples from patients with peripheral von Recklinghausen's disease were studied by competition radioreceptor assays and radioimmunoassays for biologically active 2.5S subunit of nerve growth factor (NGF). These specimens were fractionated at low pH to partially purify a 2.5S NGF-like activity that specifically competes for the binding of radioisotope-labeled 2.5S NGF to its receptor on human melanoma cells. In seven patients with peripheral neurofibromatosis, statistically significant elevations of this 2.5S NGF competing activity were found: approximately 85% of the patients tested had competing activities outside the 95% confidence limits of the normal population. No elevations of competing activity were observed when these serum fractions were examined by a specific radioimmunoassay for purified 2.5S NGF. These conflicting observations may suggest the existence of two molecular species demonstrating NGF-like activity: one sharing antigenic determinants with mouse 2.5S NGF and the other antigenically unrelated. We identified an NGF binding activity of high molecular weight in human serum. This activity is not elevated in the serum of patients with peripheral neurofibromatosis.



Author Affiliations

From the Laboratory of Viral Carcinogenesis, National Cancer Institute, Bethesda, Md. Dr Fabricant is now with the Louisiana State University Eye Center, New Orleans.


Footnotes

Accepted for publication June 10, 1980.

Reprint requests to 136 S Roman, New Orleans, LA 70112 (Dr Fabricant).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurofibromatosis-associated lung disease: a case series and literature review
Zamora et al.
Eur Respir J 2007;29:210-214.
ABSTRACT | FULL TEXT  

Circulating Growth Factor Levels Are Associated with Tumorigenesis in Neurofibromatosis Type 1
Mashour et al.
Clin. Cancer Res. 2004;10:5677-5683.
ABSTRACT | FULL TEXT  

The human gene for the beta subunit of nerve growth factor is located on the proximal short arm of chromosome 1
Francke et al.
Science 1983;222:1248-1251.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.